A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis-Reference-Cited by-同舟云学术

A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis

Published:2011-05 Issue:5 Volume:54 Page:1011-1019
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ratziu Vlad,de Ledinghen Victor,Oberti Fréderic,Mathurin Philippe,Wartelle-Bladou Claire,Renou Christophe,Sogni Philippe,Maynard Marianne,Larrey Dominique,Serfaty Lawrence,Bonnefont-Rousselot Dominique,Bastard Jean-Philippe,Rivière Marc,Spénard Jean

Funder

Axcan Pharma Inc

Publisher

Elsevier BV

Subject

Hepatology

Reference59 articles.

1. The natural history of nonalcoholic fatty liver disease: a population-based cohort study;Adams;Gastroenterology,2005

2. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial;Angulo;J Hepatol,1999

3. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD;Angulo;Hepatology,2007

4. Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis;Balmerm;Liver Int,2009

5. Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats;Bellentani;Biochem Biophys Res Commun,1996

Cited by 267 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of intestinal flora in nonobese nonalcoholic fatty liver disease patients and the impact of ursodeoxycholic acid treatment on these features;Lipids;2024-09-09

2. Breakthrough in the Treatment of Metabolic Associated Steatotic Liver Disease: Is it all over?;Digestive and Liver Disease;2024-09

3. EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD);Journal of Hepatology;2024-09

4. Ursodeoxycholic Acid\'s Effectiveness in the Management of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis;Euroasian journal of hepato-gastroenterology;2024-06-12

5. Optimal probiotic combinations for treating nonalcoholic fatty liver disease: A systematic review and network meta-analysis;Clinical Nutrition;2024-06